Abbvie Inc Stock Price. Everything You Need To Know About The Abbvie Inc Stock! Abbvie Inc Stock Price. Everything You Need To Know About The Abbvie Inc Stock!

AbbVie, Inc. is a biopharmaceutical company that specializes in researching, developing and selling pharmaceutical products. With its headquarters located in North Chicago, Illinois, AbbVie currently employs 50,000 full-time employees. The company went public on 2013-01-02 and has since been offering a range of products in various therapeutic categories.

AbbVie’s products include immunology products like Humira, Skyrizi, and Rinvoq, oncology products such as Imbruvica and Venclexta, and aesthetics products like Botox Cosmetic, Juvederm Collection, and others. The company also offers neuroscience products such as Botox Therapeutic, Vraylar, Duopa, and Duodopa, Ubrelvy; eye care products like Lumigan, Alphagan, and Restasis; women’s health products such as Lo Loestrin, Orilissa, and others. Additionally, AbbVie provides other products like Mavyret, Creon, Lupron, Linzess, and Synthroid.

AbbVie’s shares are sold to wholesalers, government agencies, healthcare facilities, and independent retailers. As of today, the stock price today for AbbVie, Inc. is available for premarket viewing. With a large market cap, AbbVie, Inc. continues to discover and develop innovative antibody medicines that target difficult-to-drug disease-causing proteins such as G protein-coupled receptors (GPCRs).

Abbvie Inc Stock Price. Everything You Need To Know About The Abbvie Inc Stock! performance

  • Employees 50000
  • Company HQ North Chicago
  • Website
  • ABBV Asset Type Common Stock
  • ABBV Market Capitalization 296.1B
  • Earnings Per Share 3.36
  • Dividends Per Share 6.06
  • Dividend Date 2024-05-15
  • Quarterly Earnings Growth 4.964

Are you looking to invest in the pharmaceutical industry from Malaysia, Thailand, Indonesia, or Vietnam? Abbvie could be the perfect stock for you. As a global biopharmaceutical company, Abbvie is dedicated to discovering, developing, and delivering innovative therapies to help people around the world. With a strong portfolio of products, including market-leading treatments in areas such as immunology, oncology, and neuroscience, Abbvie provides great potential for long-term growth. But how can you invest in this stock? At Zorion, we offer a user-friendly investment platform that allows retail investors from Malaysia, Thailand, Indonesia, and Vietnam to invest in real US stocks like Abbvie. With our investment insights and recommendations, as well as educational resources, you can make informed decisions and further your investment knowledge. Start investing in Abbvie today with Zorion.

Want To Buy Abbvie Inc Stock From Malaysia, Indonesia, Thailand or Philippines? You may also be interested in: